We've found
27,461
archived clinical trials in
Hematology
We've found
27,461
archived clinical trials in
Hematology
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Updated: 1/1/1970
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Updated: 1/1/1970
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Updated: 1/1/1970
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Updated: 1/1/1970
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Updated: 1/1/1970
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Updated: 1/1/1970
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Updated: 1/1/1970
Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Status: Archived
Updated: 1/1/1970
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Updated: 1/1/1970
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Updated: 1/1/1970
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Updated: 1/1/1970
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Updated: 1/1/1970
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Updated: 1/1/1970
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Updated: 1/1/1970
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Updated: 1/1/1970
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintraâ„¢, TLK199 Tablets) for Treatment of Severe Chronic Neutropenia
Status: Archived
Updated: 1/1/1970
Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases
A PhaseI/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 Inhibitor AZD1480 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF
Status: Archived
Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases
Updated: 1/1/1970
A PhaseI/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 Inhibitor AZD1480 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF
Status: Archived
Updated: 1/1/1970
Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases
A PhaseI/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 Inhibitor AZD1480 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF
Status: Archived
Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases
Updated: 1/1/1970
A PhaseI/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 Inhibitor AZD1480 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF
Status: Archived
Updated: 1/1/1970
Hemangioma Growth During the First 6 Months of Life
Hemangioma Growth During the First 6 Months of Life
Status: Archived
Hemangioma Growth During the First 6 Months of Life
Updated: 1/1/1970
Hemangioma Growth During the First 6 Months of Life
Status: Archived
Updated: 1/1/1970
Hemangioma Growth During the First 6 Months of Life
Hemangioma Growth During the First 6 Months of Life
Status: Archived
Hemangioma Growth During the First 6 Months of Life
Updated: 1/1/1970
Hemangioma Growth During the First 6 Months of Life
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
Updated: 1/1/1970
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
Updated: 1/1/1970
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
Updated: 1/1/1970
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
Updated: 1/1/1970
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
A Study of the Safety and Effectiveness of CNTO 328 When Added to Velcade-Melphalan-Prednisone in Patients With Multiple Myeloma
Updated: 1/1/1970
A Randomized, Open-Label, Phase 2 Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreated Multiple Myeloma.
Status: Archived
Updated: 1/1/1970
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Efficacy and Safety of Fibrinogen Concentrate (Human) (FCH) for On-demand Treatment of Acute Bleeding in Subjects With Congenital Fibrinogen Deficiency
Status: Archived
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Updated: 1/1/1970
Efficacy and Safety of Fibrinogen Concentrate (Human) (FCH) for On-demand Treatment of Acute Bleeding in Subjects With Congenital Fibrinogen Deficiency
Status: Archived
Updated: 1/1/1970
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Efficacy and Safety of Fibrinogen Concentrate (Human) (FCH) for On-demand Treatment of Acute Bleeding in Subjects With Congenital Fibrinogen Deficiency
Status: Archived
Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Updated: 1/1/1970
Efficacy and Safety of Fibrinogen Concentrate (Human) (FCH) for On-demand Treatment of Acute Bleeding in Subjects With Congenital Fibrinogen Deficiency
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Updated: 1/1/1970
Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
Status: Archived
Updated: 1/1/1970